Quantitation of macropinocytosis in glioblastoma based on high-content analysis

Bo Wang1, Xuan Yao1, Qiang Dong2

  • 1Key Lab of Neurology of Gansu Province, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Department of Neurosurgery, the Second Hospital of Lanzhou University, Lanzhou 730030, Gansu, China; The Second Medical College of Lanzhou University, Lanzhou,730030, Gansu, China.

PubMed
Abstract

Insights

A new high-content analysis method quantifies macropinocytosis, a cellular process. This technique aids in understanding glioblastoma survival mechanisms and developing novel therapies.

Area of Science:

  • Cell Biology
  • Biotechnology

Background:

  • Macropinocytosis is crucial for cellular uptake but difficult to assess at scale.
  • Existing methods are laborious and unsuitable for high-throughput screening.
  • Development of sensitive and specific assays for macropinocytosis is needed.

Purpose of the Study:

  • To introduce a quantitative, time-saving method for macropinocytosis detection using high-content analysis (HCA).
  • To evaluate the role of macropinocytosis in glioblastoma (GBM) cell survival under nutrient-deficient conditions.

Main Methods:

  • High-content analysis (HCA) was employed for quantitative macropinocytosis detection.
  • A 'macropinosome index' was defined for standardized assessment.
  • Cell proliferation was assessed using the CCK8 assay.

Main Results:

  • The HCA method provides a novel, objective, and high-throughput assay for macropinocytosis.
  • Macropinocytosis was shown to enhance GBM cell survival in L-glutamine-deficient environments.
  • An increased macropinosome index was observed in GBM cells under L-glutamine deprivation.

Conclusions:

  • HCA offers a robust platform for macropinocytosis assessment.
  • Macropinocytosis plays a role in GBM cell adaptation to the tumor microenvironment.
  • Targeting macropinocytosis presents a potential therapeutic strategy for GBM.

Related Concept Videos